Chemical industry – Page 110
-
Business
PCSK9 inhibitors against cholesterol problems perform well
Sanofi has reported Phase II data for a new drug candidate for lowering cholesterol levels in patients already taking statins
-
Business
Light materials from Bayer
Bayer has launched a lightweight material designed to replace steel in railway locomotive and carriage construction
-
Business
AbbVie emerges from Abbott split
US healthcare giant Abbott has renamed the branded drugs part of its business
-
Business
EPA proposes new rules for five chemicals
The US Environmental Protection Agency has proposed new rules that would force companies to report any new use
-
Business
Court throws out patent covering drug dosing
The US Supreme Court has said that medical tests that rely on correlations between drug doses and treatment cannot be patented
-
Business
GSK to build £350m factory in UK
GlaxoSmithKline (GSK) has announced £350 million plans to build its first new UK production plant for almost 40 years in Ulverston, Cumbria
-
News
GSK to build £350 million factory in UK
Tax breaks in the UK budget have prompted GSK to reaffirm its commitment
-
News
India green lights production of patented cancer drug
For the first time India has invoked a ‘compulsory licence’ clause to cut the cost of a patented anti-cancer drug
-
Business
Children's lungs are more susceptible to nanoparticles
Infant lungs are particularly prone to nanoparticle deposition, be it from pollution or inhaled medicines
-
Business
Irish government plans to pick winners in research
Science funding will be targeted to areas that will deliver the biggest return on investment
-
Careers
To ECHA his own
The EU’s Reach regulation involves a huge data gathering operation - Kaihsu Tai is working right at its heart
-
BusinessMapping the reactivity of single nanocatalysts
The catalytic behaviour of gold nanorods varies across their surface in unexpected ways
-
BusinessNanocellulose has paper potential
Material would cut the carbon footprint of paper substantially – by 15% or more, the researchers say
-
FeatureRising from the ashes
Neil Sinclair reports on some exciting new ventures emerging from redundant chemical and pharmaceutical plants
-
OpinionThe elements of drug design
Drug discovery requires experimentation, says Derek Lowe. But chemists can be reluctant to stray from the elements they know and love
-
Business
Business roundup: March 2012
Pharmaceutical Collaboration for neglected tropical diseases A group of 13 pharma companies, three national governments and several global health organisations has come together to target 10 neglected tropical diseases (NTDs) with $785 million (?497 million) in R&D funding. The group aims to ’accelerate progress toward eliminating or controlling [this set ...
-
Opinion
The language of the lab
Derek Lowe wonders what the lab lingua franca might be in the years to come
-
Business
Business roundup: February 2012
Pharmaceutical BMS spends $2.5 billion on antiviral firm Pharma giant Bristol-Myers Squibb (BMS) has struck a deal to buy US biotech Inhibitex for $2.5 billion (?1.6 billion). The move will stock BMS’s pipeline with antivirals, most notably INX-189, a nucleotide polymerase inhibitor which is in Phase II trials for treating ...
-
Business
Business roundup: January 2012
Pharmaceutical Mental health drug use up More than one fifth of adults in the US took a mental health drug of some kind in 2010, according to a new report. The authors from Medco Health Solutions, a US pharmacy services company, found that use was higher for women than for ...
-
Opinion
Rewards of repurposing
Derek Lowe discusses how companies are increasingly trying to do more with the compounds they already know a lot about